82448-134 : Gomekli 1 mg Oral Tablet, for Suspension


NDC: 82448-134
Labeler: Springworks Therapeutics, Inc.
Product Type: Human Prescription Drug
Drug Name:  Gomekli
Dosage Form: Oral Tablet, for Suspension
Application #: NDA219379
Rev. Date: 


NDC Package Codes:

  • 82448-134-42: 42 TABLET, FOR SUSPENSION IN 1 BOTTLE (82448‑134‑42)
  • 82448-134-84: 84 TABLET, FOR SUSPENSION IN 1 BOTTLE (82448‑134‑84)

Active Ingredients:

  • Mirdametinib

Dosage Strength:

  • 1 mg

Pharmaceutical Classes:

  • Kinase Inhibitor [EPC]
  • Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]
  • Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 82448-130 Gomekli 1 mg Oral Capsule by Springworks Therapeutics, Inc.
  • 82448-260 Gomekli 2 mg Oral Capsule by Springworks Therapeutics, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 82448-134 QR Code

< Prev: 82448-130Next: 82448-150 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.